Heartflow

About Heartflow

Heartflow is a publicly traded medical technology company that uses AI to analyze CT scans and create personalized 3D models of the heart for diagnosing and managing coronary artery disease.

Heartflow develops AI-powered software that transforms standard coronary CT angiography (CCTA) scans into personalized 3D models of the heart. Their platform, Heartflow One, includes FFR CT Analysis to assess blood flow, Plaque Analysis to quantify plaque, and Roadmap Analysis for efficient reading. The technology is cleared for use in the US, UK, Europe, Japan, and Canada, and has been used on over 650,000 patients across more than 1,800 institutions. Heartflow generates revenue through per-analysis fees reimbursed by payers and providers.